Analyse des systèmes : Questions médicales fréquentes
Nom anglais: Systems Analysis
Descriptor UI:D013597
Tree Number:L01.906
Termes MeSH sélectionnés :
Attention Deficit Disorder with Hyperactivity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Analyse des systèmes : Questions médicales les plus fréquentes",
"headline": "Analyse des systèmes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Analyse des systèmes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-04",
"dateModified": "2025-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Analyse des systèmes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sciences de l'information",
"url": "https://questionsmedicales.fr/mesh/D007254",
"about": {
"@type": "MedicalCondition",
"name": "Sciences de l'information",
"code": {
"@type": "MedicalCode",
"code": "D007254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cybernétique",
"alternateName": "Cybernetics",
"url": "https://questionsmedicales.fr/mesh/D003491",
"about": {
"@type": "MedicalCondition",
"name": "Cybernétique",
"code": {
"@type": "MedicalCode",
"code": "D003491",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.099"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Méthode Delphi",
"alternateName": "Delphi Technique",
"url": "https://questionsmedicales.fr/mesh/D003697",
"about": {
"@type": "MedicalCondition",
"name": "Méthode Delphi",
"code": {
"@type": "MedicalCode",
"code": "D003697",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.197"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Recherche opérationnelle",
"alternateName": "Operations Research",
"url": "https://questionsmedicales.fr/mesh/D009874",
"about": {
"@type": "MedicalCondition",
"name": "Recherche opérationnelle",
"code": {
"@type": "MedicalCode",
"code": "D009874",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.394"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rétroaction",
"alternateName": "Feedback",
"url": "https://questionsmedicales.fr/mesh/D005246",
"about": {
"@type": "MedicalCondition",
"name": "Rétroaction",
"code": {
"@type": "MedicalCode",
"code": "D005246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.394.211"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Théorie des probabilités",
"alternateName": "Probability Theory",
"url": "https://questionsmedicales.fr/mesh/D011338",
"about": {
"@type": "MedicalCondition",
"name": "Théorie des probabilités",
"code": {
"@type": "MedicalCode",
"code": "D011338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.394.622"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Programmation linéaire",
"alternateName": "Programming, Linear",
"url": "https://questionsmedicales.fr/mesh/D011382",
"about": {
"@type": "MedicalCondition",
"name": "Programmation linéaire",
"code": {
"@type": "MedicalCode",
"code": "D011382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.394.748"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Intégration de systèmes",
"alternateName": "Systems Integration",
"url": "https://questionsmedicales.fr/mesh/D018511",
"about": {
"@type": "MedicalCondition",
"name": "Intégration de systèmes",
"code": {
"@type": "MedicalCode",
"code": "D018511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.787"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flux de travaux",
"alternateName": "Workflow",
"url": "https://questionsmedicales.fr/mesh/D057188",
"about": {
"@type": "MedicalCondition",
"name": "Flux de travaux",
"code": {
"@type": "MedicalCode",
"code": "D057188",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "L01.906.893"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Analyse des systèmes",
"alternateName": "Systems Analysis",
"code": {
"@type": "MedicalCode",
"code": "D013597",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yongli Situ",
"url": "https://questionsmedicales.fr/author/Yongli%20Situ",
"affiliation": {
"@type": "Organization",
"name": "Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou 510632, Guangdong, China."
}
},
{
"@type": "Person",
"name": "Ruxiu Gao",
"url": "https://questionsmedicales.fr/author/Ruxiu%20Gao",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, 12453Guangdong Medical University, Zhanjiang 524023,Guangdong, China."
}
},
{
"@type": "Person",
"name": "Lei Lei",
"url": "https://questionsmedicales.fr/author/Lei%20Lei",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, 12453Guangdong Medical University, Zhanjiang 524023,Guangdong, China."
}
},
{
"@type": "Person",
"name": "Li Deng",
"url": "https://questionsmedicales.fr/author/Li%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, 12453Guangdong Medical University, Zhanjiang 524023,Guangdong, China."
}
},
{
"@type": "Person",
"name": "Qinying Xu",
"url": "https://questionsmedicales.fr/author/Qinying%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, 12453Guangdong Medical University, Zhanjiang 524023,Guangdong, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan.",
"datePublished": "2023-03-11",
"url": "https://questionsmedicales.fr/article/36906694",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41386-023-01555-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pediatric Off-label Antipsychotic Use for Attention-Deficit/Hyperactivity Disorder.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35965110",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clinthera.2022.07.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Age within schoolyear and attention-deficit hyperactivity disorder in Scotland and Wales.",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35637502",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-022-13453-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37666665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1523/JNEUROSCI.0982-23.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Attention Deficit Hyperactivity Disorder (ADHD) and the gut microbiome: An ecological perspective.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37594987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0273890"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sciences de l'information",
"item": "https://questionsmedicales.fr/mesh/D007254"
},
{
"@type": "ListItem",
"position": 3,
"name": "Analyse des systèmes",
"item": "https://questionsmedicales.fr/mesh/D013597"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Analyse des systèmes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Analyse des systèmes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Analyse des systèmes",
"description": "Comment évaluer l'efficacité d'un système de santé ?\nQuels outils sont utilisés pour l'analyse des systèmes ?\nQu'est-ce qu'une analyse SWOT en santé ?\nComment identifier les goulets d'étranglement dans un système ?\nQuel rôle joue la technologie dans l'analyse des systèmes ?",
"url": "https://questionsmedicales.fr/mesh/D013597?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Analyse des systèmes",
"description": "Quels symptômes indiquent un dysfonctionnement du système de santé ?\nComment les patients perçoivent-ils les systèmes de santé ?\nQuels signes montrent une surcharge du système de santé ?\nComment les inégalités affectent-elles les symptômes ?\nQuels symptômes sont liés à une mauvaise gestion des ressources ?",
"url": "https://questionsmedicales.fr/mesh/D013597?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Analyse des systèmes",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment évaluer l'impact des programmes de prévention ?\nQuel est le rôle de l'éducation dans la prévention ?\nComment les politiques de santé influencent-elles la prévention ?\nQuels obstacles à la prévention existent ?",
"url": "https://questionsmedicales.fr/mesh/D013597?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Analyse des systèmes",
"description": "Comment optimiser les traitements dans un système de santé ?\nQuel est l'impact des traitements standardisés ?\nComment évaluer l'efficacité des traitements ?\nQuel rôle joue la formation dans l'amélioration des traitements ?\nComment intégrer les nouvelles technologies dans les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D013597?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Analyse des systèmes",
"description": "Quelles complications peuvent survenir dans un système de santé ?\nComment prévenir les complications dans les traitements ?\nQuel est l'impact des complications sur les coûts de santé ?\nComment les complications affectent-elles la qualité des soins ?\nQuels facteurs augmentent le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D013597?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Analyse des systèmes",
"description": "Quels sont les principaux facteurs de risque en santé ?\nComment les facteurs socio-économiques influencent-ils la santé ?\nQuel rôle joue l'environnement dans les facteurs de risque ?\nComment évaluer les facteurs de risque dans une population ?\nQuels comportements augmentent les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D013597?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un système de santé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par des indicateurs de performance, tels que les taux de guérison."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour l'analyse des systèmes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les diagrammes de flux et les modèles de simulation sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une analyse SWOT en santé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une méthode d'évaluation des forces, faiblesses, opportunités et menaces d'un système de santé."
}
},
{
"@type": "Question",
"name": "Comment identifier les goulets d'étranglement dans un système ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des analyses de flux de travail pour repérer les étapes ralentissant le processus."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la technologie dans l'analyse des systèmes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La technologie facilite la collecte de données et l'analyse, améliorant la prise de décision."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un dysfonctionnement du système de santé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des temps d'attente prolongés et des erreurs médicales fréquentes peuvent indiquer des problèmes."
}
},
{
"@type": "Question",
"name": "Comment les patients perçoivent-ils les systèmes de santé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les perceptions varient selon l'accès, la qualité des soins et la communication avec les professionnels."
}
},
{
"@type": "Question",
"name": "Quels signes montrent une surcharge du système de santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation des admissions et des consultations peut signaler une surcharge du système."
}
},
{
"@type": "Question",
"name": "Comment les inégalités affectent-elles les symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inégalités d'accès aux soins peuvent exacerber les symptômes et retarder le traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une mauvaise gestion des ressources ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards dans les traitements et des pénuries de médicaments peuvent en être des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de sensibilisation et les programmes de dépistage sont des stratégies clés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des programmes de prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est mesuré par des indicateurs de santé publique et des études d'impact."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de l'éducation dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation des patients sur les comportements sains est cruciale pour la prévention."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé influencent-elles la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de santé bien conçues favorisent l'accès aux soins préventifs et aux vaccinations."
}
},
{
"@type": "Question",
"name": "Quels obstacles à la prévention existent ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les obstacles incluent le manque d'accès aux soins, la désinformation et les coûts élevés."
}
},
{
"@type": "Question",
"name": "Comment optimiser les traitements dans un système de santé ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'optimisation passe par l'analyse des données cliniques et l'amélioration des protocoles."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des traitements standardisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements standardisés améliorent la cohérence des soins et réduisent les variations."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des analyses de résultats à long terme."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la formation dans l'amélioration des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La formation continue des professionnels de santé est essentielle pour mettre à jour les pratiques."
}
},
{
"@type": "Question",
"name": "Comment intégrer les nouvelles technologies dans les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'intégration se fait par des essais cliniques et des évaluations de l'impact sur les soins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir dans un système de santé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections nosocomiales et des erreurs de médication."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications dans les traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des protocoles stricts et une surveillance continue des patients."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des complications sur les coûts de santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications augmentent les coûts en prolongeant les séjours hospitaliers et les traitements."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité des soins ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité des soins et la satisfaction des patients."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les comorbidités et le non-respect des traitements prescrits."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque en santé ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'obésité et le manque d'activité physique."
}
},
{
"@type": "Question",
"name": "Comment les facteurs socio-économiques influencent-ils la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs socio-économiques affectent l'accès aux soins et les comportements de santé."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement dans les facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'environnement peut influencer la santé par la pollution et l'accès à des aliments sains."
}
},
{
"@type": "Question",
"name": "Comment évaluer les facteurs de risque dans une population ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des études épidémiologiques et des enquêtes de santé publique."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements comme la consommation excessive d'alcool et le sédentarisme augmentent les risques."
}
}
]
}
]
}
There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhe...
Off-label antipsychotic use for behavioral symptoms in pediatric attention-deficit/hyperactivity disorder (ADHD) poses safety concerns, and evidence to support such use is limited. This study aims to ...
A cohort study was conducted using IQVIA PharMetrics Plus for Academics data from 2007 to 2020. Youth 5 to 15 years of age at the index ADHD visit were included in the cohort. The index ADHD visit mee...
Of 41,098 youth with ADHD who met the study criteria, 4557 were diagnosed with DBD during follow-up. The incidence of antipsychotic initiation was 19.6 (95% CI, 18.7- 20.5) per 1000 person-years. Afte...
Antipsychotic use among youth with ADHD is more likely in the presence of DBD, suggesting that an off-label use is for behavior problems....
Previous studies suggest an association between age within schoolyear and attention-deficit hyperactivity disorder (ADHD). Scotland and Wales have different school entry cut-off dates (six months apar...
Routine education and health records of 1,063,256 primary and secondary schoolchildren in Scotland (2009-2013) and Wales (2009-2016) were linked. Logistic regression was used to examine the relationsh...
Amongst children in their expected school year, 8,721 (0.87%) had treated ADHD (Scotland 0.84%; Wales 0.96%). In Wales, ADHD increased with decreasing age (youngest quartile, adjusted OR 1.32, 95% CI ...
Children younger within schoolyear are more likely to be treated for ADHD, suggesting immaturity may influence diagnosis. However, these children are more likely to be held back in countries that perm...
Prevailing frameworks propose that a key feature of attention-deficit/hyperactivity disorder (ADHD) is lower motivation. An important component of motivation is the willingness to engage in cognitivel...
Attention Deficit Hyperactivity Disorder (ADHD) is an increasingly prevalent neuropsychiatric disorder characterized by hyperactivity, inattention, and impulsivity. Symptoms emerge from underlying def...
In our outpatient pediatric and adult psychiatry centers, we reserve psychostimulants for predominantly inattentive attention deficit hyperactivity disorder (ADHD) due to the potential for appetite an...
50 patients (35 children) received mean doses of atomoxetine 60 mg (25-100 mg once daily) followed by VER 300 mg (100-600 mg once daily) after a 5-day atomoxetine washout. Both atomoxetine and VER wer...
From the baseline total ADHD-RS-5 mean score (40.3 ± 10.3), improvements were greater on VER (13.9 ± 10.2) than atomoxetine (33.1 ± 12.1; t = - 10.12, p < 0.00001) in inattention (t = - 8.57, p < 0.00...
Pediatric and adult ADHD patients who have experienced less than optimal response to atomoxetine demonstrate rapid improvement in inattention and in hyperactivity/impulsivity with greater tolerability...
Attention Deficit Hyperactivity Disorder (ADHD) is associated with a range of adverse outcomes in adult life. However it is unclear whether the risk pathways to adverse adult outcomes are established ...
We examined associations between broadly defined child-limited (remitted) and persistent ADHD (assessed using the ADHD subscale of the Strengths and Difficulties Questionnaire) with social outcomes (l...
Up to 20% of young-people with less favourable social outcomes at age 25 had persistent ADHD. Persistent ADHD was associated with an increased likelihood of being not in education, employment or train...
Our findings highlight the importance of continued monitoring and management of ADHD symptoms and related social as well as clinical outcomes across development into adulthood. Future research is need...
Treatments for Adult ADHD include stimulants, two non-stimulant medications, as well as cognitive-behavioral therapy (CBT). These pharmacological agents are often associated with side effects, contrib...
We systematically searched MEDLINE, EMBASE, EMCARE, PsycINFO, Web of Science, Cochrane Library, and Clinicaltrials.gov. The searches included all publications in English up to June 27, 2022. We includ...
Our scoping review included a total of 39 studies. Only one study employed a randomized and placebo-controlled design to directly measure the effect of cannabis on ADHD, and no significant effect was ...
Given the current evidence, cannabis is not recommended for people with ADHD. Limitations of the literature include the absence of objective measurements for cannabis exposure and ADHD symptoms, heter...
Abnormal cerebellar development has been implicated in attention-deficit/hyperactivity disorder (ADHD), although cerebro-cerebellar functional connectivity (FC) has yet to be examined in ADHD. Our obj...
We analyzed a dataset of 106 individuals with ADHD (68 children, 38 adolescents) and 62 healthy comparison individuals (34 children, 28 adolescents) from the publicly available ADHD-200 dataset. We id...
Compared to comparisons, ADHD showed higher cerebro-cerebellar FC in the superior temporal gyrus within the somatomotor network. Interactions of diagnosis and age were identified in the supplementary ...
Increased cerebro-cerebellar FC in the superior temporal gyrus within the somatomotor network could underlie impairments in cognitive control and somatic motor function in ADHD. In addition, increasin...